About Novo Nordisk
Novo Nordisk is a healthcare company with an 84-year history of innovation and achievement in diabetes care. The company has the broadest diabetes product portfolio in the industry, including the most advanced products within the area of insulin delivery systems. In addition to diabetes care, Novo Nordisk has a leading position within areas such as hemostasis management, growth hormone therapy, and hormone therapy for women. Novo Nordisk's business is driven by the Triple Bottom Line: a commitment to economic success, environmental soundness, and social responsibility to employees and customers. With headquarters in Denmark, Novo Nordisk employs more than 25,000 employees in 79 countries, and markets its products in 179 countries. Novo Nordisk's B shares are listed on the stock exchanges in Copenhagen and London. Its ADRs are listed on the New York Stock Exchange under the symbol 'NVO'. For global information, visit novonordisk.com; for United States information, visit novonordisk-us.com.
About Discovery Health Media Enterprises
Discovery Health Media Enterprises includes the Discovery Health and
FitTV television networks and online assets including
http://www.discoveryhealth.com, as well as its Continuing Medical Education
(CME) business and Discovery's first stand-alone VOD service, Discovery
Health On-Call. Discovery Health Media Enterprises is part of Discovery
Communications, the number-one nonfiction media company reaching more than
1.5 billion cumulative subscribers in over 170 countries. Discovery's
100-plus worldwide networks are led by Discovery Channel, TLC, Animal
Planet, The Science Channel, Discovery Health and HD Theater, with digital
media properties including HowStuffWorks.com. Discovery Communications is
owned by Discovery Holding Co. (Nasdaq:
| SOURCE Discovery Health Copyright©2007 PR Newswire. All rights reserved |